Bank of America’s Endologix Inc ELGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-7,590
| Closed | -$6K | – | 7431 |
|
|
2020
Q2 | $6K | Hold |
7,590
| – | – | ﹤0.01% | 6548 |
|
|
2020
Q1 | $5K | Buy |
7,590
+7,290
| +2,430% | +$8.93K | ﹤0.01% | 6517 |
|
|
2019
Q4 | $0 | Sell |
300
-538
| -64% | -$1.5K | ﹤0.01% | 7725 |
|
|
2019
Q3 | $3K | Sell |
838
-6,049
| -88% | -$35.2K | ﹤0.01% | 6969 |
|
|
2019
Q2 | $50K | Buy |
6,887
+1,504
| +28% | +$10.3K | ﹤0.01% | 6307 |
|
|
2019
Q1 | $35K | Sell |
5,383
-49,860
| -90% | -$329K | ﹤0.01% | 6334 |
|
|
2018
Q4 | $395K | Buy |
55,243
+49,611
| +881% | +$553K | ﹤0.01% | 5089 |
|
|
2018
Q3 | $108K | Buy |
5,632
+3,729
| +196% | +$133K | ﹤0.01% | 5835 |
|
|
2018
Q2 | $108K | Sell |
1,903
-5,641
| -75% | -$286K | ﹤0.01% | 5761 |
|
|
2018
Q1 | $319K | Buy |
7,544
+3,226
| +75% | +$139K | ﹤0.01% | 5110 |
|
|
2017
Q4 | $230K | Buy |
4,318
+1,340
| +45% | +$70.8K | ﹤0.01% | 5341 |
|
|
2017
Q3 | $133K | Sell |
2,978
-2,300
| -44% | -$105K | ﹤0.01% | 5560 |
|
|
2017
Q2 | $256K | Sell |
5,278
-21,274
| -80% | -$1.25M | ﹤0.01% | 5208 |
|
|
2017
Q1 | $1.92M | Sell |
26,552
-152
| -0.6% | -$10.1K | ﹤0.01% | 3899 |
|
|
2016
Q4 | $1.53M | Sell |
26,704
-50,062
| -65% | -$4.59M | ﹤0.01% | 4000 |
|
|
2016
Q3 | $9.83M | Sell |
76,766
-12,434
| -14% | -$1.59M | ﹤0.01% | 2260 |
|
|
2016
Q2 | $11.1M | Buy |
89,200
+27,297
| +44% | +$3.14M | ﹤0.01% | 2091 |
|
|
2016
Q1 | $5.18M | Sell |
61,903
-17,046
| -22% | -$1.41M | ﹤0.01% | 2752 |
|
|
2015
Q4 | $7.82M | Buy |
78,949
+20,706
| +36% | +$2.22M | ﹤0.01% | 2511 |
|
|
2015
Q3 | $7.14M | Sell |
58,243
-40,400
| -41% | -$5.48M | ﹤0.01% | 2524 |
|
|
2015
Q2 | $15.1M | Buy |
98,643
+4,741
| +5% | +$782K | ﹤0.01% | 1614 |
|
|
2015
Q1 | $16M | Buy |
93,902
+1,566
| +2% | +$237K | 0.01% | 1518 |
|
|
2014
Q4 | $14.1M | Buy |
92,336
+5,253
| +6% | +$656K | 0.01% | 1654 |
|
|
2014
Q3 | $9.23M | Sell |
87,083
-1,678
| -2% | -$234K | ﹤0.01% | 2018 |
|
|
2014
Q2 | $13.5M | Buy |
88,761
+10,369
| +13% | +$1.38M | ﹤0.01% | 1686 |
|
|
2014
Q1 | $10.1M | Buy |
78,392
+66,523
| +560% | +$10.3M | ﹤0.01% | 1776 |
|
|
2013
Q4 | $2.07M | Buy |
11,869
+10,469
| +748% | +$1.8M | ﹤0.01% | 3291 |
|
|
2013
Q3 | $226K | Sell |
1,400
-1,382
| -50% | -$218K | ﹤0.01% | 5356 |
|
|
2013
Q2 | $369K | Buy |
+2,782
| New | +$393K | ﹤0.01% | 5044 |
|
Other funds holding ELGX
Bank of America's ELGX Position: Q3 2020 in Review
Bank of America sold out of Endologix Inc (ELGX) in Q3 2020, closing a stake of 7,590 shares — an estimated $6K sold.
Bank of America first reported a position in ELGX in Q2 2013 and held it in 29 quarters. The position peaked at $16M in Q1 2015. 6 funds tracked by Wall St. Rank hold ELGX as of Q3 2020.
- Bank of America reported no remaining Endologix Inc position as of Q3 2020 after selling out during the quarter.
- Bank of America sold 7,590 Endologix Inc shares in Q3 2020, an estimated $6K.
- Bank of America first reported a position in Endologix Inc in Q2 2013 and held it in 29 quarters.
- Bank of America's Endologix Inc position peaked at $16M in Q1 2015.
- 6 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2020.
Based on Bank of America's 13F filing for Q3 2020, filed 13 Nov 2020.